November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
HEROS 2.0 trial using CAR T-cells targeting HER2 protein has shown safety and clinical benefit – St. Baldrick’s Foundation
Jul 10, 2024, 10:54

HEROS 2.0 trial using CAR T-cells targeting HER2 protein has shown safety and clinical benefit – St. Baldrick’s Foundation

St. Baldrick’s Foundation shared on LinkedIn:

“Exciting news on the horizon for sarcoma patients from researchersĀ at Baylor College of Medicine! The latest HEROS 2.0 trial using CAR T-cells targeting HER2 protein has shown safety and clinical benefit, with 50% of patients seeing positive results. With continued research and multiple infusions, we’re seeing huge potential for long-term cancer-free outcomes.

Learn more about this research that was partially funded by St. Baldrickā€™s.”

Source: St. Baldrick’s Foundation/LinkedIn